These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2036334)

  • 1. Acute hemodynamic effects of molsidomine in patients with ischemic cardiomyopathy.
    Caralis DG; Kyriakides Z; Ioakimides C
    Cardiovasc Drugs Ther; 1991 Feb; 5(1):155-6. PubMed ID: 2036334
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hemodynamic effect of molsidomine in coronary patients with heart failure with clinically manifest nitrate tolerance].
    Störk T; Möckel M; Störk S; Piske G; Danne O; Bodemann T; Müller R; Eichstädt H; Hochrein H
    Z Kardiol; 1993 May; 82(5):293-301. PubMed ID: 8328179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Problems in acute therapy of coronary heart disease using drugs that reduce preload and afterload].
    Krüger R
    Med Klin (Munich); 1987 Jan; 1():19-23. PubMed ID: 3106750
    [No Abstract]   [Full Text] [Related]  

  • 4. Preload or afterload reduction: which is more beneficial for patients with ischemic heart disease?
    Caralis DG; Kyriakides Z
    Cardiovasc Drugs Ther; 1988 May; 2(1):79-82. PubMed ID: 3154698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molsidomine in rest and exercise conditions in coronary heart disease. Acute and long-term effects].
    Jansen W; Meyer L; Osterspey A; Eggeling T; Tauchert M; Hilger HH
    Med Klin (Munich); 1986 Jun; 81(14):489-95. PubMed ID: 3097469
    [No Abstract]   [Full Text] [Related]  

  • 6. [The effect of molsidomine preparations on the coronary and myocardial reserves of patients with IHD complicated by circulatory failure].
    Ol'binskaia LI; Sizova ZhM; Alekperov EE
    Ter Arkh; 1994; 66(8):30-2. PubMed ID: 7985149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of stress-induced angina pectoris and chronic heart failure with molsidomine].
    Beyerle A; Rudolph W
    Med Klin (Munich); 1986 Jan; 81(2):41-4. PubMed ID: 3537664
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of haemodynamic effects of nifedipine and molsidomine in patients with coronary artery disease.
    Kyriakidis M; Vyssoulis G; Sfikakis P; Kyriakidis C; Pitsavos C; Valsamis K; Nomikos V; Toutouzas P
    Eur J Clin Pharmacol; 1989; 37(5):443-7. PubMed ID: 2598982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in the antiischaemic effects of molsidomine and isosorbide dinitrate.
    Jost S
    Eur Heart J; 1992 May; 13(5):720. PubMed ID: 1618218
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of the hemodynamic responses to molsidomine and isosorbide dinitrate in congestive heart failure.
    Unger P; Vachiery JL; de Cannière D; Staroukine M; Berkenboom G
    Am Heart J; 1994 Sep; 128(3):557-63. PubMed ID: 8074020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infusions with molsidomine and isosorbide-5-mononitrate in congestive heart failure: mechanisms underlying attenuation of effects.
    Lehmann G; Hähnel I; Reiniger G; Lampen M; Beyerle A; Schömig A
    J Cardiovasc Pharmacol; 1998 Feb; 31(2):212-20. PubMed ID: 9475262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial metabolic and hemodynamic effects of dobutamine in heart failure complicating coronary artery disease.
    Pozen RG; DiBianco R; Katz RJ; Bortz R; Myerburg RJ; Fletcher RD
    Circulation; 1981 Jun; 63(6):1279-85. PubMed ID: 7226474
    [No Abstract]   [Full Text] [Related]  

  • 13. [Molsidomine in the treatment of coronary insufficiency].
    Weber S
    Rev Med Interne; 1987; 8(4):437-43. PubMed ID: 2892240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic effects of molsidomine at rest and during submaximal and maximal exercise in patients with coronary artery disease limited by exertional angina pectoris.
    Detry JM; Melin J; Brasseur LA; Cosyns J; Rousseau MF
    Am J Cardiol; 1981 Jan; 47(1):109-15. PubMed ID: 6893896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of korvaton and korinfar on systemic circulation in heart failure patients].
    Koshlia VI
    Vrach Delo; 1986 Aug; (8):23-5. PubMed ID: 3776152
    [No Abstract]   [Full Text] [Related]  

  • 16. [The hemodynamic effectiveness of molsidomine infusions in patients with acute coronary insufficiency].
    Krüger R; Grewe R
    Med Klin (Munich); 1994 Jul; 89 Suppl 2():26-9. PubMed ID: 7968897
    [No Abstract]   [Full Text] [Related]  

  • 17. Hemodynamic response to molsidomine in patients with ischemic cardiomyopathy tolerant to isosorbide dinitrate.
    Unger P; Leone A; Staroukine M; Degré S; Berkenboom G
    J Cardiovasc Pharmacol; 1991 Dec; 18(6):888-94. PubMed ID: 1725903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the clinical usefulness of molsidomine in ischemic heart disease].
    Janicki K; Ochmański W; Kmieć M
    Pol Tyg Lek; 1986 Jun 23-30; 41(25-26):829-34. PubMed ID: 3534821
    [No Abstract]   [Full Text] [Related]  

  • 19. Salutary hemodynamic and sustained clinical beneficial effects of nisoldipine, a new calcium channel blocker, in patients with recurrent ischemia and severe heart failure.
    Kimchi A; Ellrodt AG; Charuzi Y; Shell W; Murata GH
    Am Heart J; 1985 Aug; 110(2):496-8. PubMed ID: 4025130
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of corvaton on ischemic left-ventricular damage and hemodynamic indicators in patients with acute myocardial infarction].
    Khal'fen ESh; Shvarts IL; Zolotarev VA
    Kardiologiia; 1988 Oct; 28(10):101-2. PubMed ID: 3226037
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.